Chen Jianbei, Lei Chaofang, Li Xiaojuan, Wu Qian, Liu Chenyue, Ma Qingyu, Chen Jiaxu
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Formula-pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, China.
Front Pharmacol. 2022 Aug 4;13:925514. doi: 10.3389/fphar.2022.925514. eCollection 2022.
Depression is an emotional disorder that is problematic in psychiatry owing to its unclear etiology and unknown pathogenesis. Traditional Chinese medicine formulations such as Xiaoyaosan have been widely used throughout history to treat depression. In this review, we have focused on recent evidences elucidating the links between Xiaoyaosan and the treatment of depression. Data from animal and clinical studies, focusing on the pharmacological mechanisms, clinical applications, and effective materials that form the basis for the treatment of depression are presented and discussed. We found that the antidepressant effects of Xiaoyaosan are related to the effects of monoamine neurotransmitters, regulation of the hypothalamic-pituitary-adrenal axis, neuroplasticity, synaptic plasticity, inflammatory response, neuroprotection, brain-gut axis, regulation of intestinal microbiota, oxidative stress, and autophagy for reducing neuronal apoptosis. This review highlights the current evidence supporting the use of Xiaoyaosan as an antidepressant and provides an overview of the potential mechanisms involved.
抑郁症是一种情感障碍,因其病因不明和发病机制未知而在精神病学领域成为难题。诸如逍遥散之类的中药配方在历史上已被广泛用于治疗抑郁症。在本综述中,我们重点关注了阐明逍遥散与抑郁症治疗之间联系的最新证据。呈现并讨论了来自动物和临床研究的数据,这些数据聚焦于构成抑郁症治疗基础的药理机制、临床应用及有效成分。我们发现逍遥散的抗抑郁作用与单胺类神经递质的作用、下丘脑-垂体-肾上腺轴的调节、神经可塑性、突触可塑性、炎症反应、神经保护、脑-肠轴、肠道微生物群的调节、氧化应激及自噬以减少神经元凋亡有关。本综述突出了支持将逍遥散用作抗抑郁药的当前证据,并概述了其中涉及的潜在机制。